| Name | Title | Contact Details |
|---|
Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.
WellDyneRx is a full-service, national pharmacy benefit manager (PBM) that makes the little things matter for our clients, employees, partners, and members.
Moses Lake Community Health Center is a non-profit, community-driven, and patient-centered healthcare organization. They provide high-quality, compassionate, and comprehensive primary healthcare services for the entire family, with a special focus on t...
Play On Sports Arena London - Join Us for Indoor Cricket, Indoor Football, Indoor Netball, Indoor Softball, Indoor Baseball, Dodgeball and many more sports. Play On Sports Arena London - The Largest Multisport Arena in London, Essex, Middlesex and the ...
Nu-Med Plus, Inc. is a medical device development company created to explore medical applications of newly developed technologies. The strategy is to concentrate on high growth potential markets where there are visible, distinct needs recognized by the medical community that can be addressed by Nu-Med Plus and its technical expertise. Initial research and product development has been in the delivery of nitric oxide gas for therapeutic use.